Pfizer breaks ground on new biologics clinical manufacturing facility

By Melissa Fassbender contact

- Last updated on GMT

A mock-up of the new Andover, MA-based biologics clinical manufacturing facility. (Image: Pfizer)
A mock-up of the new Andover, MA-based biologics clinical manufacturing facility. (Image: Pfizer)

Related tags: Disposable, Investment

Pfizer broke ground on its new Andover, MA-based biologics clinical manufacturing facility this week, which will feature single-use and disposable technologies.

The company will invest more than $200m in development of the 175,000 sq. ft. facility, which is expected to be operational by January 2019.

According to Pfizer, the new clinical manufacturing facility was designed with five independent manufacturing suites.

The facility will feature single-use bioreactors and disposable process technologies and will be fully enabled to support next generation manufacturing.

The Andover campus currently includes seven buildings housing laboratories, clinical and commercial manufacturing suites, and other support areas.

The campus also features a multiproduct manufacturing facility.

As part of the new investment, Pfizer will hire approximately 75 new employees to support clinical manufacturing.

Related news

Show more

Related products

show more

Manufacturing of hiPSC-Derived Cardiomyocytes

Manufacturing of hiPSC-Derived Cardiomyocytes

Eppendorf for Bioprocess – Solutions that grow with you | 29-Oct-2020 | Application Note

Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Related suppliers

Follow us

Products

View more

Webinars